Correlation Between Bio Gene and Home Consortium

Can any of the company-specific risk be diversified away by investing in both Bio Gene and Home Consortium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Gene and Home Consortium into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bio Gene Technology and Home Consortium, you can compare the effects of market volatilities on Bio Gene and Home Consortium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Gene with a short position of Home Consortium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Gene and Home Consortium.

Diversification Opportunities for Bio Gene and Home Consortium

-0.64

Correlation Coefficient

Bio Gene  Home Consortium

Excellent diversification

The 3 months correlation between Bio and Home is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Bio Gene Technology and Home Consortium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Home Consortium and Bio Gene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Gene Technology are associated (or correlated) with Home Consortium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Home Consortium has no effect on the direction of Bio Gene i.e., Bio Gene and Home Consortium go up and down completely randomly.

Pair Corralation between Bio Gene and Home Consortium

Assuming the 90 days trading horizon Bio Gene Technology is expected to under-perform the Home Consortium. In addition to that, Bio Gene is 1.44 times more volatile than Home Consortium. It trades about -0.11 of its total potential returns per unit of risk. Home Consortium is currently generating about 0.0 per unit of volatility. If you would invest  1,010  in Home Consortium on October 7, 2024 and sell it today you would lose (15.00) from holding Home Consortium or give up 1.49% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Bio Gene Technology  vs.  Home Consortium

Bio Gene Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Home Consortium

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Home Consortium are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, Home Consortium unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bio Gene and Home Consortium

The main advantage of trading using opposite Bio Gene and Home Consortium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Gene position performs unexpectedly, Home Consortium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Home Consortium will offset losses from the drop in Home Consortium's long position.

The idea behind Bio Gene Technology and Home Consortium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.